Search

Author/Creator Nakayama, H.

1. 1955 Primary systemic therapy by dual HER2 blockage with lapatinib (La) + trastuzumab (T) for Japanese patients (pts) with HER2+ breast cancer (BC): Association of La toxicity and dose with treatment efficacy. (September 2015)

Authors:
Yamashita, T.; Masuda, N.; Yamamoto, N.; Kondo, N.; Bando, H.; Akiyoshi, S.; Ohtani, S.; Takano, T.; Inoue, K.; Fujisawa, T.; Ishiguro, H.; Nakayama, H.; Aogi, K.; Amano, S.; Ozaki, H.; Yasojima, H.; Kasai, H.; Kataoka, T.R.; Morita, S.; Toi, M.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S317
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 2016 Early results of phase II trial of perioperative oxaliplatin and capecitabine (XELOX) without radiotherapy for high-risk rectal cancer (CORONA I). (September 2015)

Authors:
Uehara, K.; Nakayama, G.; Ishigure, K.; Kobayashi, S.; Hiramatsu, H.; Nakayama, H.; Yamashita, K.; Sakamoto, E.; Tojima, Y.; Kawai, S.; Kodera, Y.; Nagino, M.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S333
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗